Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Visceral leishmaniasis in Afghanistan

Toby Leslie, Sarah Saleheen, Mohammad Sami, Ismail Mayan, Najibullah Mahboob, Kathy Fiekert, Annick Lenglet, Rosalynn Ord and Richard Reithinger
CMAJ August 01, 2006 175 (3) 245; DOI: https://doi.org/10.1503/cmaj.060202
Toby Leslie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Saleheen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Sami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismail Mayan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Najibullah Mahboob
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathy Fiekert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annick Lenglet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalynn Ord
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Reithinger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Despite being the third most important vector-borne diseases worldwide in terms of burden of disease, the leishmaniases are one of the so-called “neglected diseases.”

Since the massive humanitarian re-construction efforts began after the fall of the Taliban in 2002, Afghanistan is slowly emerging from 2 decades of civil war. Nevertheless, country health indicators are still among the worst globally, with many preventable diseases such as typhoid fever, diarrhea and measles common throughout the country.1 Besides having the world's largest incidence of cutaneous leishmaniasis, with an estimated 250 000 cases annually,2 Afghanistan may now have another public health problem on their hands: visceral leishmaniasis.

Epidemiology: Visceral leishmaniasis is a chronic, systemic disease characterized by fever, (hepato)splenomegaly, lymphadenopathy, pancytopenia, weight loss, weakness and, if left untreated, death.3 The disease is usually caused by Leishmania donovani or L. infantum, transmitted to human and animal hosts by the bite of phlebotomine sandflies. Although in most disease-endemic areas transmission is zoonotic, with domestic dogs as the main reservoir, transmission is anthroponotic in some areas, such as India and Sudan.

Clinical management: In most areas where visceral leishmaniasis is endemic, suspected cases are diagnosed on the basis of positive Giemsa-stained smears of lymph node, bone marrow or spleen aspirates.3 Recently, there also has been an increased operational use of easy-to-use serologic tests (e.g., immunochromatographic dipsticks or direct agglutination tests). Following parasitologic confirmation, patients are usually given pentavalent antimony therapy (20 mg/kg intramuscularly or intravenously) for 30 days.3 Other therapeutic approaches include miltefosine and amphotericin B, especially in disease-endemic areas where increased unresponsiveness to antimony has been observed.

Figure1

Figure. Female phlebotomine sandfly. Sometimes mistaken for mosquitoes, these sandflies are common vectors for various diseases, including leishmaniasis. Photo by: CDC/WHO

Prevention: Strategies to prevent and control visceral leishmaniasis are aimed at reducing exposure to the sandfly vector. This can be achieved by improving housing, using insecticide-treated bednets or curtains, spraying houses indoors with residual insecticides and — in zoonotic foci — collaring dogs with insecticide-impregnated dog collars. Although these strategies have proven to be highly effective, they have usually been implemented only on a foci-specific scale rather than nationally or regionally.

Visceral leishmaniasis in Afghanistan: Although several hundreds of cases of visceral leishmaniasis are reported every year from Afghanistan's neighbouring countries (Iran, Pakistan, Turkmenistan and Uzbekistan), there have been only 23 cases reported from Afghanistan since 1980 in the scientific literature.

Recently, 6 parasitologically confirmed cases of visceral leishmaniasis in patients from 3 Afghan provinces were observed in HealthNet International's leishmaniasis treatment centre in Kabul. The patients' demographic and clinical characteristics are given in Table 1. This increased detection in the number of cases is of concern, since it follows the report of 2 US soldiers stationed in Afghanistan with the disease4 and 2 cases from Baghlan province in 2004 (unpublished data from HealthNet International, Kabul).

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1.

Because climate restricts the sandfly vector's season in Afghanistan from April to October, it is probable that the patients, given their individual case histories, contracted the disease in 2004 or 2003. Most of the cases reported here were from the northeastern province of Baghlan. They could have resulted from a recent outbreak or, most probably, be coincident cumulative reporting of a disease with low endemicity (e.g., owing to better access to health care). Of interest is that most of the patients had originally received a diagnosis of malaria, which is endemic throughout Afghanistan.

There is little historical or current data on visceral leishmaniasis in Afghanistan: neither vectors nor reservoirs have been incriminated, and it is unknown whether the transmission cycle is anthroponotic or zoonotic. Epidemiologic research is highly warranted. The increased detection of visceral leishmaniasis in Afghanistan will require a reassessment of leishmaniasis prevention and control strategies. Unlike cutaneous leishmaniasis, the visceral form is potentially fatal, with case-fatality rates as high as 85%. Large-scale occurrence of a potentially fatal disease in a population that is largely malnourished and impoverished would be devastating. Leishmaniasis management guidelines in Afghanistan will have to be updated to include available treatment regimens for the visceral form of the disease. Additional prevention and control measures, such as the reduction of animal reservoirs (if any), the introduction and upscaling of personal protection and vector control, awareness campaigns, and training for health professionals, will require significant input from international funding agencies, above and beyond what is currently available for cutaneous leishmaniasis control.

Footnotes

  • Acknowledgements: HealthNet International's Malaria and Leishmaniasis Control Programme is funded by the European Commission (DG1). The views expressed herein are solely those of the authors and do not necessarily reflect those of their respective organizations, institutions or funding agencies. The principal investigator, Toby Leslie, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

REFERENCES

  1. 1.↵
    Waldmann R, Hanif H. The public health system in Afghanistan: current issues. Islamabad: Afghanistan Research and Evaluation Unit; 2002. Available: www.areu.org.af/publications/waldman_health.pdf (accessed 2006 Jun 01).
  2. 2.↵
    Reithinger R, Mohsen M, Aadil K, et al. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis 2003;9:727-9.
    OpenUrlPubMed
  3. 3.↵
    Division of Control of Tropical Diseases, World Health Organization (WHO). Manual on visceral leishmaniasis control. Geneva: WHO; 1996. Available: www.who.int/leishmaniasis/surveillance/training/en/WHO_LEISH_96.40.pdf (accessed 2006 Jun 1).
  4. 4.↵
    Two cases of visceral leishmaniasis in U.S. military personnel — Afghanistan, 2002–2004. MMWR Morb Mortal Wkly Rep 2004;53:265-8.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 175 (3)
CMAJ
Vol. 175, Issue 3
1 Aug 2006
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Visceral leishmaniasis in Afghanistan
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Visceral leishmaniasis in Afghanistan
Toby Leslie, Sarah Saleheen, Mohammad Sami, Ismail Mayan, Najibullah Mahboob, Kathy Fiekert, Annick Lenglet, Rosalynn Ord, Richard Reithinger
CMAJ Aug 2006, 175 (3) 245; DOI: 10.1503/cmaj.060202

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Visceral leishmaniasis in Afghanistan
Toby Leslie, Sarah Saleheen, Mohammad Sami, Ismail Mayan, Najibullah Mahboob, Kathy Fiekert, Annick Lenglet, Rosalynn Ord, Richard Reithinger
CMAJ Aug 2006, 175 (3) 245; DOI: 10.1503/cmaj.060202
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Dans ce numéro
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • “Superscan” in diffusion-weighted imaging with background body suppression magnetic resonance imaging
  • Using intranasal corticosteroids
  • Langerhans cell histiocytosis in a 5-month-old baby
Show more Practice

Similar Articles

Collections

  • Topics
    • Infectious diseases

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire